ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023

ERYTECH’s shareholders are hereby informed of the Annual General Meeting which will be held on June 23, 2023 at 09:30am CEST at the Hôtel Intercontinental, 2 rue Scribe, 75009 Paris…

Continue ReadingERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023

ERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies

ERYTECH and PHERECYDES announced their proposed strategic combination intended to create a global player in extended phage therapy and accelerate the development of a portfolio of drug candidates targeting pathogenic…

Continue ReadingERYTECH and PHERECYDES Announce Proposed Combination Intending to Create Global Leader in Extended Phage Therapies
Menu